Abortion Pill: upcoming dates

Recent

• Health09/23/2026@HealthDesk

  Senate HELP Committee Holds Heidi Overton's FDA Commissioner Hearing

  430 Dirksen Senate Office Building, Washington, D.C.U.S. Food and Drug Administration

  

  Starts 09/24/2026 2:30PM UTCSCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins85% CONFIDENCEOverall confidence: 85%How well the pin's source and references back up its dates.Weighted average of how firmly 6 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better8 days agoGiven as scheduled, per help.senate.gov^[1][3]: "Date: Thursday, September 24, 2026 / Time: 10:30 AM ET/ 9:30 AM CT / Location: 430 Dirksen Senate Office Building"; it takes place "directly after the HELP Committee votes" on other nominations, so it may start a little later.

  The Senate HELP Committee questions Dr. Heidi Overton, President Trump's pick for FDA commissioner, at 10:30 a.m. ET in 430 Dirksen. If confirmed, the White House domestic policy aide would take over an agency that has lost more than 3,000 staff in the past year.

  00
• Law09/25/2026@LawDesk

  Fifth Circuit Hears Louisiana's Appeal Against Mail-Order Mifepristone

  United States Court of Appeals Fifth Circuit, 600, Camp Street, Central Business District, French Quarter, New Orleans, Orleans Parish, Louisiana, 70130, United StatesUnited States Court of Appeals for the Fifth Circuit

  

  Starts 09/09/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins83% CONFIDENCEOverall confidence: 83%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better23 days agoThe court's recording of 26-30203 State of Louisiana v. FDA gives "Hearing Date: Wednesday, September 9, 2026 Courtroom: En Banc Courtroom".^[1]

  A Fifth Circuit panel of Judges Richman, Higginson and Douglas heard Louisiana's bid to end telehealth prescribing of mifepristone and pressed the state hard on whether it has standing to sue.

  00
• Law09/25/2026@LawDesk

  Supreme Court Restores Mail Access to Mifepristone in Louisiana Case

  Supreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United StatesSupreme Court of the United States

  

  Starts 05/14/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins84% CONFIDENCEOverall confidence: 84%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better141 days agoThe order in Nos. 25A1207 and 25A1208 is dated "[May 14, 2026]" and says "The applications for stay ... are granted".^[1]

  The Supreme Court stayed the Fifth Circuit's order in Louisiana v. FDA, so mifepristone can again be prescribed by telehealth and sent by mail while the case goes on; Justices Thomas and Alito dissented.

  10
• Law09/25/2026@LawDesk

  Fifth Circuit Reinstates In-Person Dispensing for Mifepristone

  United States Court of Appeals Fifth Circuit, 600, Camp Street, Central Business District, French Quarter, New Orleans, Orleans Parish, Louisiana, 70130, United StatesUnited States Court of Appeals for the Fifth Circuit

  

  Starts 05/01/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins82% CONFIDENCEOverall confidence: 82%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better154 days agoThe opinion in No. 26-30203 is stamped "FILED May 1, 2026" and orders that "the motion to stay the 2023 REMS under 5 U.S.C. § 705 pending appeal is GRANTED".^[1]

  A Fifth Circuit panel granted Louisiana a stay of the FDA's 2023 mifepristone rules, ending telehealth prescribing and mail or pharmacy dispensing of the abortion pill nationwide until the Supreme Court stepped in.

  00
• Law09/25/2026@WomenDesk

  Texas HB 7 Takes Effect, Letting Citizens Sue Abortion-Pill Providers

  Texas State Capitol, 112, East 11th Street, Downtown, Austin, Travis County, Texas, 78701, United StatesTexas Legislature

  

  Starts 12/04/2025CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins85% CONFIDENCEOverall confidence: 85%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better302 days agoThe Legislature's bill history for 89(2) HB 7 reads "Effective on . . . December 4, 2025" after "Signed by the Governor 09/17/2025"; the act has no expiry clause.^[1]

  Texas's Woman and Child Protection Act takes effect, letting private citizens sue anyone who makes, mails or provides abortion pills into Texas for at least $100,000 per violation, while barring suits against the woman.

  00
• Health09/25/2026@HealthDesk

  FDA Approves Evita Solutions' Generic Mifepristone

  Mahan Court, Federal Research Center, White Oak, Montgomery County, Maryland, 20993, United StatesEvita Solutions

  

  Starts 09/30/2025 2:20PM UTCCONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins83% CONFIDENCEOverall confidence: 83%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better1.0 years agoThe ANDA 216616 approval letter says "the ANDA is approved, effective on the date of this letter" and is digitally signed "Date: 9/30/2025 10:20:02AM".^[1]

  The FDA approved Evita Solutions' 200 mg mifepristone tablets as the second generic of the abortion pill, less than two weeks after HHS promised a safety review of the drug.

  00
• Law09/25/2026@LawDesk

  Supreme Court Rejects Challenge to Mifepristone in FDA v. Alliance

  Supreme Court of the United States, 1, 1st Street Northeast, Ward 6, Washington, District of Columbia, 20543, United StatesSupreme Court of the United States

  

  Starts 06/13/2024CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins84% CONFIDENCEOverall confidence: 84%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better2.3 years agoThe slip opinion in No. 23-235 is headed "Argued March 26, 2024—Decided June 13, 2024".^[1]

  A unanimous Supreme Court threw out anti-abortion doctors' challenge to the FDA's rules for the abortion pill mifepristone, holding they had no standing to sue, so mail and telehealth access stayed in place.

  00